Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Atossa Therapeutics Inc fell by 22.43m. Cash Flow from Investing was negative at 14.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 20.94m for operations while cash used for financing totalled 1.48m.
Cash flow per share | -0.2062 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6374 |
---|---|
Tangible book value per share | 0.6374 |
More ▼
Balance sheet in USDView more
Current ratio | 14.35 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼